Literature DB >> 19390878

DNA adducts of antitumor cisplatin preclude telomeric sequences from forming G quadruplexes.

Pavla Heringova1, Jana Kasparkova, Viktor Brabec.   

Abstract

We studied the effect of antitumor cisplatin and inefficient transplatin on the structure and stability of G quadruplexes formed by the model human telomere sequence 5'-GGG(TTAGGG)(3)-3' using circular dichroism, UV-monitored thermal denaturation, and gel electrophoresis. In addition, to investigate whether there is a connection between the ability of cisplatin or transplatin to affect telomerase activity and stability of G quadruplexes, we also used a modified telomere repeat amplification protocol assay that uses an oligonucleotide substrate for telomerase elongation susceptible to forming a G quadruplex. The results indicate that cisplatin is more efficient than transplatin in disturbing the quadruplex structure, thereby precluding telomeric sequences from forming quadruplexes. On the other hand, the results of this work also demonstrate that in absence of free platinum complex, DNA adducts of antitumor cisplatin inhibit telomerase catalysis, so the mechanism underlying this inhibition does not involve formation of the G quadruplexes which are not elongated by telomerase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19390878     DOI: 10.1007/s00775-009-0508-6

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  76 in total

Review 1.  G-quadruplex DNA: a potential target for anti-cancer drug design.

Authors:  H Han; L H Hurley
Journal:  Trends Pharmacol Sci       Date:  2000-04       Impact factor: 14.819

2.  Small molecule/nucleic acid affinity chromatography: application for the identification of telomerase inhibitors which target its key RNA/DNA heteroduplex.

Authors:  C West; R Francis; S H Friedman
Journal:  Bioorg Med Chem Lett       Date:  2001-10-22       Impact factor: 2.823

Review 3.  Biochemical aspects of telomerase function.

Authors:  Lea Harrington
Journal:  Cancer Lett       Date:  2003-05-15       Impact factor: 8.679

4.  Inhibition of telomerase by G-quartet DNA structures.

Authors:  A M Zahler; J R Williamson; T R Cech; D M Prescott
Journal:  Nature       Date:  1991-04-25       Impact factor: 49.962

5.  TRAP-LIG, a modified telomere repeat amplification protocol assay to quantitate telomerase inhibition by small molecules.

Authors:  Julie Reed; Mekala Gunaratnam; Monica Beltran; Anthony P Reszka; Ramon Vilar; Stephen Neidle
Journal:  Anal Biochem       Date:  2008-05-17       Impact factor: 3.365

6.  Euplotes telomerase: evidence for limited base-pairing during primer elongation and dGTP as an effector of translocation.

Authors:  P W Hammond; T R Cech
Journal:  Biochemistry       Date:  1998-04-14       Impact factor: 3.162

7.  Cisplatin (cis-Pt(NH(3))(2)Cl(2)) and cis-[Pt(NH(3))(2)(H(2)O)(2)](2+) Intrastrand Cross-Linking Reactions at the Telomere GGGT DNA Sequence Embedded in a Duplex, a Hairpin, and a Bulged Duplex: Use of Mg(2+) and Zn(2+) to Convert a Hairpin to a Bulged Duplex.

Authors:  Julie M. Villanueva; Xin Jia; Paulos G. Yohannes; Paul W. Doetsch; Luigi G. Marzilli
Journal:  Inorg Chem       Date:  1999-12-27       Impact factor: 5.165

8.  A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line.

Authors:  Miho Furuta; Katsura Nozawa; Masaharu Takemura; Shunji Izuta; Takashi Murate; Masayuki Tsuchiya; Kenji Yoshida; Naoki Taka; Yuji Nimura; Shonen Yoshida
Journal:  Int J Cancer       Date:  2003-05-10       Impact factor: 7.396

9.  Sequence-dependent distortions induced in DNA by monofunctional platinum(II) binding.

Authors:  V Brabec; J Reedijk; M Leng
Journal:  Biochemistry       Date:  1992-12-15       Impact factor: 3.162

Review 10.  The resurgence of platinum-based cancer chemotherapy.

Authors:  Lloyd Kelland
Journal:  Nat Rev Cancer       Date:  2007-07-12       Impact factor: 60.716

View more
  9 in total

1.  Biological activity of enantiomeric complexes [PtCl(2)L (2)] (L (2) is aromatic bisphosphanes and aromatic diamines).

Authors:  Sophie Bombard; Marzia Bruna Gariboldi; Elena Monti; Elisabetta Gabano; Luca Gaviglio; Mauro Ravera; Domenico Osella
Journal:  J Biol Inorg Chem       Date:  2010-03-24       Impact factor: 3.358

2.  Platination of telomeric DNA by cisplatin disrupts recognition by TRF2 and TRF1.

Authors:  Isabelle Ourliac-Garnier; Anaïs Poulet; Razan Charif; Simon Amiard; Frédérique Magdinier; Keyvan Rezaï; Eric Gilson; Marie-Josèphe Giraud-Panis; Sophie Bombard
Journal:  J Biol Inorg Chem       Date:  2010-02-27       Impact factor: 3.358

3.  Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanisms.

Authors:  Orit Uziel; Einat Beery; Vladimir Dronichev; Katty Samocha; Sergei Gryaznov; Lola Weiss; Shimon Slavin; Michal Kushnir; Yardena Nordenberg; Claudette Rabinowitz; Baruch Rinkevich; Tania Zehavi; Meir Lahav
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

Review 4.  Conformational changes in DNA upon ligand binding monitored by circular dichroism.

Authors:  Yu-Ming Chang; Cammy K-M Chen; Ming-Hon Hou
Journal:  Int J Mol Sci       Date:  2012-03-12       Impact factor: 6.208

5.  Folding Kinetics of Single Human Telomeric G-Quadruplex Affected by Cisplatin.

Authors:  Hai-Peng Ju; Yi-Zhou Wang; Jing You; Xi-Miao Hou; Xu-Guang Xi; Shuo-Xing Dou; Wei Li; Peng-Ye Wang
Journal:  ACS Omega       Date:  2016-08-24

6.  Selectivity of Terpyridine Platinum Anticancer Drugs for G-quadruplex DNA.

Authors:  Elodie Morel; Claire Beauvineau; Delphine Naud-Martin; Corinne Landras-Guetta; Daniela Verga; Deepanjan Ghosh; Sylvain Achelle; Florence Mahuteau-Betzer; Sophie Bombard; Marie-Paule Teulade-Fichou
Journal:  Molecules       Date:  2019-01-23       Impact factor: 4.411

Review 7.  Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer.

Authors:  Chengyi Mao; Xiaoxi Zeng; Chao Zhang; Yushang Yang; Xin Xiao; Siyuan Luan; Yonggang Zhang; Yong Yuan
Journal:  Front Cell Dev Biol       Date:  2021-02-11

8.  Characterisation of the DNA sequence specificity, cellular toxicity and cross-linking properties of novel bispyridine-based dinuclear platinum complexes.

Authors:  Ben W Johnson; Vincent Murray; Mark D Temple
Journal:  BMC Cancer       Date:  2016-05-25       Impact factor: 4.430

Review 9.  On the Road to Fight Cancer: The Potential of G-quadruplex Ligands as Novel Therapeutic Agents.

Authors:  Irene Alessandrini; Marta Recagni; Nadia Zaffaroni; Marco Folini
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.